Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of irbesartan and doxycycline for vascular dysfunction in Marfan syndrome
2010-023612-14Phase 2Terminated
- Sponsor
- Clinical Trials and Research Governance
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of irbesartan and doxycycline in Marfan syndrome (MFS) (4 arms), sponsored by Clinical Trials and Research Governance. Primary endpoint: Change in ascending aortic distensibility. Started Dec 2012; status: terminated.
02
Drugs
irbesartandoxycycline
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on 2010-023612-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023612-14.